Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
United European Gastroenterol J. 2023 Nov;11(9):837-851. doi: 10.1002/ueg2.12471. Epub 2023 Oct 28.
About 20% of patients develop cardiac decompensation within the first year after transjugular intrahepatic portosystemic shunt (TIPS) insertion. However, risk factors for cardiac decompensation remain poorly defined. We aimed to evaluate predictors of cardiac decompensation after TIPS insertion in a large, well-defined cohort of patients with liver cirrhosis.
234 cirrhotic patients who received a TIPS at Hannover Medical School were retrospectively followed up for one year to assess the incidence of cardiac decompensation. Echocardiographic parameters and established diagnostic criteria for cardiac impairment (e.g. by the American Society of Echocardiography/ European Association of Cardiovascular Imaging (ASE/EACVI)) were investigated for an association with cardiac decompensation in a competing risk analysis. Survival was analyzed using a multivariable cox regression analysis adjusting for Freiburg index of post-TIPS survival.
Predominant TIPS indication was ascites (83%). Median age was 59 years, median MELD-score 12% and 58% were male. Overall, 41 patients (18%) developed cardiac decompensation within one year after TIPS insertion. Diastolic dysfunction according to the ASE/EACVI was diagnosed in 26% of patients at baseline and was linked to a significantly higher risk for cardiac decompensation (p = 0.025) after TIPS. When investigating individual echocardiographic baseline parameters, only pathological E/A (<0.8 or >2) was identified as a risk factor for cardiac decompensation (p = 0.015). Mortality and liver transplantation (n = 50) were significantly higher among patients who developed cardiac decompensation (HR = 5.29, p < 0.001) as well as in patients with a pathological E/A (HR = 2.34, p = 0.006). Cardiac high-risk status (44% of patients) was strongly linked to cardiac decompensation (HR = 2.93, p = 0.002) and mortality (HR = 2.24, p = 0.012).
Cardiac decompensation after TIPS is a frequent and important complication and is associated with reduced survival. American Society of Echocardiography/EACVI criteria and E/A seem to be the best parameters to predict the cardiac risk in cirrhotic patients undergoing TIPS insertion.
大约 20%的经颈静脉肝内门体分流术(TIPS)置入术后的患者在一年内会出现心功能失代偿。然而,心功能失代偿的危险因素仍未得到很好的定义。我们旨在评估在一个由大量明确诊断为肝硬化的患者组成的队列中,TIPS 术后心功能失代偿的预测因素。
回顾性随访在汉诺威医学院接受 TIPS 的 234 例肝硬化患者,以评估心功能失代偿的发生率。对超声心动图参数和已建立的心脏损伤诊断标准(例如,美国超声心动图学会/欧洲心血管成像协会(ASE/EACVI))进行竞争风险分析,以评估其与 TIPS 术后心功能失代偿的关系。使用多变量 Cox 回归分析调整 TIPS 后弗莱堡生存指数,以分析生存情况。
主要的 TIPS 适应证是腹水(83%)。中位年龄为 59 岁,中位 MELD 评分 12%,58%为男性。总体而言,41 例(18%)患者在 TIPS 术后 1 年内出现心功能失代偿。基线时根据 ASE/EACVI 诊断出舒张功能障碍的患者占 26%,与 TIPS 后心功能失代偿的风险显著增加相关(p=0.025)。在研究个别超声心动图基线参数时,只有病理性 E/A(<0.8 或>2)被确定为心功能失代偿的危险因素(p=0.015)。发生心功能失代偿的患者(HR=5.29,p<0.001)和 E/A 异常的患者(HR=2.34,p=0.006)的死亡率和肝移植(n=50)明显更高。心脏高危状态(44%的患者)与心功能失代偿(HR=2.93,p=0.002)和死亡率(HR=2.24,p=0.012)密切相关。
TIPS 术后的心功能失代偿是一种常见且重要的并发症,与生存率降低有关。美国超声心动图学会/EACVI 标准和 E/A 似乎是预测 TIPS 术后肝硬化患者心脏风险的最佳参数。